July 27, 2016 5:00 PM ET

Biotechnology

Company Overview of Five Prime Therapeutics, Inc.

Executive Profile

Franklin M. Berger CFA, BA, MA, MBA

Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Five Prime Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 20 different industries.

See Board Relationships
66$335,875

Background

Mr. Franklin M. Berger, CFA, BA, MA, MBA, is the Founder of FMR Research Inc. and also serves as its Principal. Mr. Berger is the Founder and Managing Director of FMB Research. Mr. Berger has been a Consultant to pharmaceutical and biotechnology companies, asset managers and venture capital firms since 2003. He served as the Managing Director of U.S. of Equity Research and Senior Biotechnology Analyst at J.P. Morgan Securities LLC from 1998 to 2003. While he was at the ...

Corporate Headquarters

Two Corporate Drive
South San Francisco, California 94080

United States

Phone: 415-365-5600
Fax: 415-365-5601

Board Members Memberships

Director
2007-Present
Lead Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2014-Present
Director and Chairman of Audit Committee
2015-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
2016-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee

Education

MBA
Harvard Business School
MA
Johns Hopkins University
BA
Johns Hopkins University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$59,000
Total Calculated Compensation$335,875
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Five Prime Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.